SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024096
Filing Date
2024-09-30
Accepted
2024-09-30 17:06:50
Documents
1
Period of Report
2024-09-24

Document Format Files

Seq Description Document Type Size
1 form4-09302024_090946.html 4  
1 form4-09302024_090946.xml 4 4888
  Complete submission text file 0001415889-24-024096.txt   6271
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
SALEKI-GERHARDT AZITA (Reporting) CIK: 0001563545 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 241340299